Figure - PMC

Skip to main content

An official website of the United States government

Here's how you know

Here's how you know

Official websites use .gov
A .gov website belongs to an official government organization in the United States.

Secure .gov websites use HTTPS
A lock ( ) or https:// means you've safely connected to the .gov website. Share sensitive information only on official, secure websites.

View full-text article in PMC

. 2022 Mar 9;13(3):6476–6489. doi: 10.1080/21655979.2022.2031668

Search in PMC
Search in PubMed
View in NLM Catalog
Add to search

© 2022 The Author(s). Published by Informa UK Limited, trading as Taylor & Francis Group.

This is an Open Access article distributed under the terms of the Creative Commons Attribution License (http://creativecommons.org/licenses/by/4.0/), which permits unrestricted use, distribution, and reproduction in any medium, provided the original work is properly cited.

PMC Copyright notice

Figure 4. — MiR-545-3p inhibitor reverses the suppression of FAM83H-AS1 knockdown on lung cancer cell progression. (a) The effect of FAM83H-AS1 knockdown on the miR-545-3p expression level. (b) CCK8 assay determined the effect of inhibiting the miR-545-3p and FAM83H-AS1 knockdown on the NSCLC cell proliferation. (c) The effect of inhibiting the miR-545-3p and FAM83H-AS1 knockdown on the NSCLC cell invasion. Data are represented as mean ± SD. *P < 0.05, **P < 0.001, vs.Si-NC; #P < 0.05, ##P < 0.001, vs. inhibitor-NC; ΔP<0.05, ΔΔP<0.001, vs.si-FAM83S-AS1+ inhibitor.